Consumer Healthcare Products Association executives will tell FDA that the OTC monograph system is not broken but needs improvement, in their presentation to the agency’s upcoming public hearing on the system.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?